The Swedish Birth Seat Trial

Helsingborgs Hospital

Status: Completed

Conditions: Instrumental Vaginal Births; Fetal Outcomes; Maternal Blood Loss; Perineal Outcomes; Oxytocin Augmentation for Labor

Treatments: Device: BirthRite birthing seat

Study type: Interventional

Funder types: Other

Identifiers

NCT01182038

2009/739

Details and patient eligibility

About

The purpose of this study is to determine whether birth on a birthing seat will effect numbers of instrumentally assisted vaginal births, vaginal traumas, blood loss,use of artificial oxytocin for labour augmentation and fetal outcomes.

Enrollment: 1,002 patients

Sex: Female

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• nulliparous women who understood the Swedish language sufficiently well to receive information and give informed consent
• a normal pregnancy,singleton fetus in cephalic presentation
• spontaneous onset of labor occurring between gestational weeks 37 + 0 and 41 + 6
• Body Mass Index less (BMI) than thirty
• gestational diabetes not requiring medical treatment
• women who were planning a vaginal birth after a caesarean section (VBAC)
• women induced because of spontaneous rupture of membranes with no spontaneous contractions for longer than twenty-four hours

Exclusion criteria

• multiparous women
• birth before gestational week 37
• breech presentation
• maternal BMI more than 30
• multiple pregnancy
• infectious disease
• pre-eclampsia or other conditions requiring medical care

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

1,002 participants in 2 patient groups

Birth seat group

Experimental group

Description:

Randomized to birth on a midwife designed birth seat

Treatment:

Device: BirthRite birthing seat

Non-birth seat group

No Intervention group

Description:

Randomized to birth in any other position except on the midwife designed birth seat.